Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
You must be a Standard 1 Year member to access this content.
Dechert advised Chiesi Farmaceutici S.p.A. Gide Loyrette Nouel represented BNP Paribas. Amryt Pharma was advised by Cooley. Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in...
You must be a Standard 1 Year member to access this content.
Cooley advised Snyk on the deal while Orrick represented the investors. Snyk, a cybersecurity software startup, announced its $196.5 million Series G funding round. The round was...
You must be a Standard 1 Year member to access this content.
Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
You must be a Standard 1 Year member to access this content.
Cooley advised Neogene Therapeutics on the deal. Neogene Therapeutics, a global clinical-stage biotechnology company, signed its definitive agreement to be acquired by AstraZeneca for a total consideration...
You must be a Standard 1 Year member to access this content.
Goodwin Procter, McCarthy Tétrault and Skadden, Arps, Slate, Meagher & Flom advised Ritchie Bros. Incorporated, while Cooley and Blake, Cassels & Graydon advised IAA on the...
You must be a Standard 1 Year member to access this content.
Cooley advised affiliates of Fernweh Group on the deal. Fernweh Group announced its definitive agreement with AZZ. On June 23, Fernweh and AZZ jointly announced their entry...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Vendr on the deal. Vendr, a software as a service buying platform, announced its $150 million Series B funding round, bringing the company...
You must be a Standard 1 Year member to access this content.
Cooley advised Chainalysis on the deal. Chainalysis, a blockchain data platform, announced its $170 million Series F preferred stock financing round, bringing its valuation to $8.6...
You must be a Standard 1 Year member to access this content.
Cooley advised Chingona Ventures on the deal. Chingona Ventures, a venture capital firm that invests in founders whose backgrounds uniquely position them to create businesses in...
You must be a Standard 1 Year member to access this content.
Cooley advised Kriya Therapeutics on the deal. Kriya Therapeutics, a fully integrated gene therapy company pioneering novel technologies and therapeutics, announced its $270 Million Series C financing...
You must be a Standard 1 Year member to access this content.
Cooley advised Infinity Ventures on the deal. Early-stage venture firm Infinity Ventures announced its inaugural $158 million fund. The new capital will fuel Infinity Ventures’ model, which...
You must be a Standard 1 Year member to access this content.
